Physician Condemns California’s Confusing Hemp Regulations Impacting Pediatric CBD For Seizure Treatment

Five years ago, Stephanie Bohn‘s daughter, Sadie, was struggling with life-threatening seizures due to Rett syndrome, a rare neurological disorder. Traditional pharmaceuticals failed to alleviate her symptoms, leading her doctors to recommend medical cannabis. Sadie began taking CBD oil. After three years of refining her medication, Sadie has been seizure-free for 11 months.

“We’ve seen remarkable outcomes,” Bohn, who lives in Los Angeles, told SFGATE. “All things considered, she’s thriving, and that’s because of CBD. … She probably wouldn’t be alive today if it weren’t for CBD.”

However, the ongoing regulatory battles over California’s Hemp and cannabis threaten to disrupt this progress. Assembly Bill 2223, sponsored by majority leader Cecilia Aguiar-Curry, aims to curb unregulated intoxicants sold outside California’s legal cannabis market. While addressing the intoxicating, synthetic, lab-created products with THC, which have caused problems all over the U.S., this bill could inadvertently make high-CBD, low-THC products like Sadie’s …

Full story available on Benzinga.com